BRIEF—Aqilion and Immunscape start collaboration

Sweden’s Aqilion has initiated a drug discovery and development collaboration with Immunscape.

Aqilion chief executive Sarah Fredriksson said: “Immunscape has solid drug discovery experience and expertise and the company’s innovative molecule platform is extremely interesting for Aqilion.”

Immunscape chief executive Lars Öhman said: "We are extremely pleased to have initiated this collaboration with Aqilion, which will accelerate our drug discovery efforts.”